How CJC-1295 with DAC & Ipamorelin Works

CJC-1295 with DAC & Ipamorelin is a widely researched synergistic blend combining a long-acting Growth Hormone-Releasing Hormone (GHRH) analog with a highly selective Growth Hormone Secretagogue (GHS). Together, they produce a significantly stronger and more continuous release of human growth hormone (HGH) compared to either compound individually:

• Sustained Growth Hormone Release (DAC Effect): The addition of Drug Affinity Complex (DAC) enables CJC-1295 to bind to blood albumin, drastically extending its biological half-life. This maintains elevated, steady baseline GH levels over extended periods rather than brief, isolated spikes.

• Selective Pituitary Stimulation (Ipamorelin): Ipamorelin acts as a ghrelin receptor agonist, targeting the GH secretagogue receptor (GHSR-1a) in the pituitary gland. It stimulates a clean pulse of GH without elevating cortisol, prolactin, or appetite-stimulating signaling pathways.

• Accelerated Muscle Recovery and Fat Metabolism: By elevating systemic IGF-1 (Insulin-like Growth Factor 1) levels, this high-concentration blend accelerates protein synthesis, promotes lean muscle preservation, and drives enhanced lipolysis (fat breakdown).

• Enhanced Cellular Repair and Joint Health: The synergistic elevation of GH and IGF-1 supports rapid connective tissue repair, promotes collagen synthesis in joints and skin, and encourages deeper REM sleep cycles essential for cellular regeneration.

Chemical Properties